Skip to main content
Signal8

Guglielmino Gaetano

SEC insider (Form 3/4/5 filer). CIK 0002047624. Chief Commercial Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 22, 2026. Located in PONTE VEDRA, FL.

Companies Guglielmino Gaetano has filed insider reports for

  • TREACE MEDICAL CONCEPTS, INC. (TMCI): Officer, Chief Commercial Officer
Guglielmino Gaetano profile photo

Guglielmino Gaetano

CIK: 0002047624

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TREACE MEDICAL CONCEPTS, INC. logo
TMCI

TREACE MEDICAL CONCEPTS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • TREACE MEDICAL CONCEPTS, INC. logo
    TMCI

    TREACE MEDICAL CONCEPTS, INC.

    Jan 22, 2026
    Award
    Direct
    150K shares-
  • TREACE MEDICAL CONCEPTS, INC. logo
    TMCI

    TREACE MEDICAL CONCEPTS, INC.

    Dec 1, 2025
    Tax Payment
    Direct
    20.1K shares-
  • TREACE MEDICAL CONCEPTS, INC. logo
    TMCI

    TREACE MEDICAL CONCEPTS, INC.

    Dec 1, 2025
    Tax Payment
    Direct
    2K shares-
  • TREACE MEDICAL CONCEPTS, INC. logo
    TMCI

    TREACE MEDICAL CONCEPTS, INC.

    Dec 1, 2024
    Award
    Direct
    330K shares-
  • TREACE MEDICAL CONCEPTS, INC. logo
    TMCI

    TREACE MEDICAL CONCEPTS, INC.

    Dec 1, 2024
    Award
    Direct
    33K shares-

1-5 of 5